ST2: Current status
Open Access
- 1 July 2018
- journal article
- review article
- Published by Elsevier BV in Indian Heart Journal
- Vol. 70, S96-S101
- https://doi.org/10.1016/j.ihj.2018.03.001
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart FailureJournal of Cardiac Failure, 2008
- Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart FailureJournal of the American College of Cardiology, 2008
- IL-33 reduces the development of atherosclerosisThe Journal of Experimental Medicine, 2008
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJCI Insight, 2007
- Genetic MarkersCirculation, 2004
- Surrogate Markers for Cardiovascular DiseaseCirculation, 2004
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Interleukin-1 Receptor Cluster: Gene Organization ofIL1R2, IL1R1, IL1RL2(IL-1Rrp2),IL1RL1(T1/ST2), andIL18R1(IL-1Rrp) on Human Chromosome 2qGenomics, 1999
- Wall stress and patterns of hypertrophy in the human left ventricle.JCI Insight, 1975